Your browser doesn't support javascript.
loading
The Mortality Burden of Untreated Aortic Stenosis.
Généreux, Philippe; Sharma, Rahul P; Cubeddu, Robert J; Aaron, Lucy; Abdelfattah, Omar M; Koulogiannis, Konstantinos P; Marcoff, Leo; Naguib, Mostafa; Kapadia, Samir R; Makkar, Rajendra R; Thourani, Vinod H; van Boxtel, Benjamin S; Cohen, David J; Dobbles, Michael; Barnhart, Glenn R; Kwon, Michelle; Pibarot, Philippe; Leon, Martin B; Gillam, Linda D.
Afiliação
  • Généreux P; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA. Electronic address: philippe.genereux@atlantichealth.org.
  • Sharma RP; Stanford University School of Medicine, Stanford, California, USA.
  • Cubeddu RJ; NCH Heart Institute, Naples, Florida, USA.
  • Aaron L; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Abdelfattah OM; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Koulogiannis KP; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Marcoff L; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Naguib M; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Kapadia SR; Cleveland Clinic, Cleveland, Ohio, USA.
  • Makkar RR; Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Thourani VH; Piedmont Heart and Vascular Institute, Atlanta, Georgia, USA.
  • van Boxtel BS; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
  • Cohen DJ; Cardiovascular Research Foundation, New York, New York, USA; St Francis Hospital and Heart Center, Roslyn, New York, USA.
  • Dobbles M; egnite, Inc, Aliso Viejo, California, USA.
  • Barnhart GR; egnite, Inc, Aliso Viejo, California, USA.
  • Kwon M; egnite, Inc, Aliso Viejo, California, USA.
  • Pibarot P; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
  • Leon MB; Cardiovascular Research Foundation, New York, New York, USA; Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, USA.
  • Gillam LD; Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.
J Am Coll Cardiol ; 82(22): 2101-2109, 2023 11 28.
Article em En | MEDLINE | ID: mdl-37877909
BACKGROUND: The American College of Cardiology/American Heart Association guidelines recommend the assessment and grading of severity of aortic stenosis (AS) as mild, moderate, or severe, per echocardiogram, and recommend aortic valve replacement (AVR) when the AS is severe. OBJECTIVES: The authors sought to describe mortality rates across the entire spectrum of untreated AS from a contemporary, large, real-world database. METHODS: We analyzed a deidentified real-world data set including 1,669,536 echocardiographic reports (1,085,850 patients) from 24 U.S. hospitals (egnite Database, egnite). Patients >18 years of age were classified by diagnosed AS severity. Untreated mortality and treatment rates were examined with Kaplan-Meier (KM) estimates, with results compared using the log-rank test. Multivariate hazards analysis was performed to assess associations with all-cause mortality. RESULTS: Among 595,120 patients with available AS severity assessment, the KM-estimated 4-year unadjusted, untreated, all-cause mortality associated with AS diagnosis of none, mild, mild-to-moderate, moderate, moderate-to-severe, or severe was 13.5% (95% CI: 13.3%-13.7%), 25.0% (95% CI: 23.8%-26.1%), 29.7% (95% CI: 26.8%-32.5%), 33.5% (95% CI: 31.0%-35.8%), 45.7% (95% CI: 37.4%-52.8%), and 44.9% (95% CI: 39.9%-49.6%), respectively. Results were similar when adjusted for informative censoring caused by treatment. KM-estimated 4-year observed treatment rates were 0.2% (95% CI: 0.2%-0.2%), 1.0% (95% CI: 0.7%-1.3%), 4.2% (95% CI: 2.0%-6.3%), 11.4% (95% CI: 9.5%-13.3%), 36.7% (95% CI: 31.8%-41.2%), and 60.7% (95% CI: 58.0%-63.3%), respectively. After adjustment, all degrees of AS severity were associated with increased mortality. CONCLUSIONS: Patients with AS have high mortality risk across all levels of untreated AS severity. Aortic valve replacement rates remain low for patients with severe AS, suggesting that more research is needed to understand barriers to diagnosis and appropriate approach and timing for aortic valve replacement.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Implante de Prótese de Valva Cardíaca / Substituição da Valva Aórtica Transcateter Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Implante de Prótese de Valva Cardíaca / Substituição da Valva Aórtica Transcateter Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2023 Tipo de documento: Article